Back
Ligand Pharmaceuticals Stock Price Chart
Sponsored
LGND
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
36
LGND
Ligand Pharmaceuticals
Last Price:
$108.44
Seasonality Move:
5.18%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ligand Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 108.39 | Sell |
20-day SMA: | 111.98 | Sell |
50-day SMA: | 115.5 | Sell |
200-day SMA: | 97.8 | Buy |
8-day EMA: | 108.5 | Sell |
20-day EMA: | 111.28 | Sell |
50-day EMA: | 112.52 | Sell |
200-day EMA: | 100.22 | Buy |
Ligand Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.54 | Sell |
Relative Strength Index (14 RSI): | 39.6 | Sell |
Chaikin Money Flow: | 73980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (108.21 - 119.25) | Sell |
Bollinger Bands (100): | (102.26 - 117.32) | Sell |
Ligand Pharmaceuticals Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ligand Pharmaceuticals Stock
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 105.86 while LGND 8-day simple moving average is 108.39, which is a Sell signal.
-
The stock price of LGND is 105.86 while Ligand Pharmaceuticals 20-day SMA is 111.98, which makes it a Sell.
-
Ligand Pharmaceuticals 50-day simple moving average is 115.50 while LGND share price is 105.86, making it a Sell technically.
-
LGND stock price is 105.86 and Ligand Pharmaceuticals 200-day simple moving average is 97.80, creating a Buy signal.
LGND Technical Analysis vs Fundamental Analysis
Sell
36
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a SellThe current Ligand Pharmaceuticals [LGND] share price is $105.86. The Score for LGND is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Ligand Pharmaceuticals Stock Info
Market Cap:
2B
Price in USD:
105.86
Share Volume:
92.1K
Ligand Pharmaceuticals 52-Week Range
52-Week High:
129.90
52-Week Low:
67.53
Sell
36
Ligand Pharmaceuticals (LGND)
is a Sell
Ligand Pharmaceuticals Share Price Forecast
-
What is the Ligand Pharmaceuticals stock price today?The Ligand Pharmaceuticals stock price is 105.86 USD today.
-
Will LGND stock go up or go down?Ligand Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Ligand Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ligand Pharmaceuticals is overvalued.
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 105.86 while LGND 8-day exponential moving average is 108.50, which is a Sell signal.
-
The stock price of LGND is 105.86 while Ligand Pharmaceuticals 20-day EMA is 111.28, which makes it a Sell.
-
Ligand Pharmaceuticals 50-day exponential moving average is 112.52 while LGND share price is 105.86, making it a Sell technically.
-
LGND stock price is 105.86 and Ligand Pharmaceuticals 200-day simple moving average is 100.22, creating a Buy signal.
Fundamental Analysis of Ligand Pharmaceuticals
Is Ligand Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $1.07 per share.
Technical Analysis of Ligand Pharmaceuticals
Should I short Ligand Pharmaceuticals stock?
-
LGND Moving Average Covergence Divergence (MACD) indicator is -2.54, suggesting Ligand Pharmaceuticals is a Sell
-
Ligand Pharmaceuticals Relative Strength Index (RSI) is 39.6, which suggest Ligand Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Ligand Pharmaceuticals is (108.21 - 119.25), which suggest Ligand Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Ligand Pharmaceuticals is (102.26 - 117.32), which suggest Ligand Pharmaceuticals is a Sell
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.